Double Randomized and Placebo Controlled Trail of Tianqi Pingchan Granule to Prevent Levodopa-Induced Dyskinesia

计划入组 150 人 · 首次发布于 2019 年 11 月 22 日

Phase I Open-label Study of Low-dose Ketamine Infusion Treatment in Levodopa-Induced Dyskinesia in Parkinson's Disease

计划入组 9 人 · 首次发布于 2023 年 9 月 1 日

Developing Objective Measures of Levodopa Induced Dyskinesia: (Study 1)

计划入组 36 人 · 首次发布于 2007 年 4 月 30 日

Levodopa(Dhivy, Duodopa, Duopa, Inbrija, Parcopa, Prolopa, Rytary, Sinemet, Stalevo, Corbilta (previously Levodopa/Carbidopa/Entacapone Sandoz), Levodopa/Carbidopa/Entacapone Orion)

C₉H₁₁NO₄ · Rx

Levodopa Cyclops

Carbidopa/Levodopa

HARVEST TRAVEL & LEISURE INCOME ETF UNIT CL A

United States

Neurocrine Biosciences, Inc.

United States

Veru Inc

United States

EMA Waives Pediatric Trial Requirements for Mesdopetam in Parkinson's Disease

EMA and FDA Align on Phase III Program for IRLAB's Mesdopetam in Parkinson's Disease

Ketamine Shows Promise in Restoring Motor Control in Parkinson's Patients with Dyskinesia